Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaire.
Saved in:
| Title: | Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaire. |
|---|---|
| Authors: | Engele VI; University Hospital of Psychiatry II, Medical University of Innsbruck, Austria. Electronic address: veronika.engele@i-med.ac.at., Vassiliou V; Department of Radiation Oncology, Bank of Cyprus Oncology Centre, Nicosia, Cyprus., Wheelwright S; Brighton and Sussex Medical School, University of Brighton and University of, Sussex, Brighton, United Kingdom., Sztankay M; University Hospital of Psychiatry II, Medical University of Innsbruck, Austria., Puglisi C; Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., van Leeuwaarde R; Department of Endocrinology, University Medical Center Utrecht, the Netherlands., Bleiker E; The Netherlands Cancer Institute, Amsterdam Division of Psychosocial Research and Epidemiology & Family Cancer Clinic, the Netherlands., Abdel-Razeq H; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan., Fox L; Department of Precision and Population Oncology, King's College London, United Kingdom., Lanceley A; Department of Women's Cancer, Faculty of Population Health Sciences, University College London, United Kingdom., Dabakuyo S; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Epidemiology and Quality of life Research Unit, Dijon, France., Bjelic-Radisic V; Helios Klinik Wuppertal, University Witten/Herdecke, Germany., Nordin A; East Kent Gynaecological Oncology Centre, Queen Elizabeth the Queen Mother Hospital, United Kingdom., Ioannidis G; Oncology Department, Nicosia General Hospital, State Health Services Organization, Nicosia, Cyprus., Kulís D; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Brédart A; Psycho-Oncology Unit Institut Curie, Paris, France., Schwaninger G; Institute of Human Genetics, Medical University Innsbruck, Austria., Arraras JI; Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain., Holzner B; University Hospital of Psychiatry II, Medical University of Innsbruck, Austria., Oberguggenberger AS; University Hospital of Psychiatry II, Medical University of Innsbruck, Austria. |
| Corporate Authors: | EORTC Quality of Life Group |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Feb 25; Vol. 235, pp. 116226. Date of Electronic Publication: 2026 Jan 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41544363 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaire. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Engele+VI%22">Engele VI</searchLink>; University Hospital of Psychiatry II, Medical University of Innsbruck, Austria. Electronic address: veronika.engele@i-med.ac.at.<br /><searchLink fieldCode="AU" term="%22Vassiliou+V%22">Vassiliou V</searchLink>; Department of Radiation Oncology, Bank of Cyprus Oncology Centre, Nicosia, Cyprus.<br /><searchLink fieldCode="AU" term="%22Wheelwright+S%22">Wheelwright S</searchLink>; Brighton and Sussex Medical School, University of Brighton and University of, Sussex, Brighton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sztankay+M%22">Sztankay M</searchLink>; University Hospital of Psychiatry II, Medical University of Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Puglisi+C%22">Puglisi C</searchLink>; Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy.<br /><searchLink fieldCode="AU" term="%22Pogoda+K%22">Pogoda K</searchLink>; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22van+Leeuwaarde+R%22">van Leeuwaarde R</searchLink>; Department of Endocrinology, University Medical Center Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bleiker+E%22">Bleiker E</searchLink>; The Netherlands Cancer Institute, Amsterdam Division of Psychosocial Research and Epidemiology & Family Cancer Clinic, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Abdel-Razeq+H%22">Abdel-Razeq H</searchLink>; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Fox+L%22">Fox L</searchLink>; Department of Precision and Population Oncology, King's College London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lanceley+A%22">Lanceley A</searchLink>; Department of Women's Cancer, Faculty of Population Health Sciences, University College London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dabakuyo+S%22">Dabakuyo S</searchLink>; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Epidemiology and Quality of life Research Unit, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Bjelic-Radisic+V%22">Bjelic-Radisic V</searchLink>; Helios Klinik Wuppertal, University Witten/Herdecke, Germany.<br /><searchLink fieldCode="AU" term="%22Nordin+A%22">Nordin A</searchLink>; East Kent Gynaecological Oncology Centre, Queen Elizabeth the Queen Mother Hospital, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ioannidis+G%22">Ioannidis G</searchLink>; Oncology Department, Nicosia General Hospital, State Health Services Organization, Nicosia, Cyprus.<br /><searchLink fieldCode="AU" term="%22Kulís+D%22">Kulís D</searchLink>; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Brédart+A%22">Brédart A</searchLink>; Psycho-Oncology Unit Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Schwaninger+G%22">Schwaninger G</searchLink>; Institute of Human Genetics, Medical University Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Arraras+JI%22">Arraras JI</searchLink>; Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Holzner+B%22">Holzner B</searchLink>; University Hospital of Psychiatry II, Medical University of Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Oberguggenberger+AS%22">Oberguggenberger AS</searchLink>; University Hospital of Psychiatry II, Medical University of Innsbruck, Austria. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22EORTC+Quality+of+Life+Group%22">EORTC Quality of Life Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2026 Feb 25; Vol. 235, pp. 116226. <i>Date of Electronic Publication: </i>2026 Jan 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41544363 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2026.116226 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 116226 Titles: – TitleFull: Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaire. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Engele VI – PersonEntity: Name: NameFull: Vassiliou V – PersonEntity: Name: NameFull: Wheelwright S – PersonEntity: Name: NameFull: Sztankay M – PersonEntity: Name: NameFull: Puglisi C – PersonEntity: Name: NameFull: Pogoda K – PersonEntity: Name: NameFull: van Leeuwaarde R – PersonEntity: Name: NameFull: Bleiker E – PersonEntity: Name: NameFull: Abdel-Razeq H – PersonEntity: Name: NameFull: Fox L – PersonEntity: Name: NameFull: Lanceley A – PersonEntity: Name: NameFull: Dabakuyo S – PersonEntity: Name: NameFull: Bjelic-Radisic V – PersonEntity: Name: NameFull: Nordin A – PersonEntity: Name: NameFull: Ioannidis G – PersonEntity: Name: NameFull: Kulís D – PersonEntity: Name: NameFull: Brédart A – PersonEntity: Name: NameFull: Schwaninger G – PersonEntity: Name: NameFull: Arraras JI – PersonEntity: Name: NameFull: Holzner B – PersonEntity: Name: NameFull: Oberguggenberger AS IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 02 Text: 2026 Feb 25 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-0852 Numbering: – Type: volume Value: 235 Titles: – TitleFull: European journal of cancer (Oxford, England : 1990) Type: main |
| ResultId | 1 |